Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Beginning Cash Balance: 2018-2025

Historic Beginning Cash Balance for Evolus (EOLS) over the last 8 years, with Sep 2025 value amounting to $61.7 million.

  • Evolus' Beginning Cash Balance fell 34.09% to $61.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $85.0 million, marking a year-over-year increase of 119.81%. This contributed to the annual value of $62.8 million for FY2024, which is 16.53% up from last year.
  • Evolus' Beginning Cash Balance amounted to $61.7 million in Q3 2025, which was down 9.07% from $67.9 million recorded in Q2 2025.
  • Evolus' 5-year Beginning Cash Balance high stood at $146.3 million for Q1 2022, and its period low was $22.2 million during Q2 2021.
  • Over the past 3 years, Evolus' median Beginning Cash Balance value was $62.8 million (recorded in 2024), while the average stood at $65.5 million.
  • As far as peak fluctuations go, Evolus' Beginning Cash Balance skyrocketed by 381.13% in 2022, and later tumbled by 70.50% in 2023.
  • Evolus' Beginning Cash Balance (Quarterly) stood at $107.8 million in 2021, then tumbled by 39.17% to $65.6 million in 2022, then crashed by 41.00% to $38.7 million in 2023, then soared by 119.81% to $85.0 million in 2024, then slumped by 34.09% to $61.7 million in 2025.
  • Its last three reported values are $61.7 million in Q3 2025, $67.9 million for Q2 2025, and $87.0 million during Q1 2025.